- Home
- NXT vs KRYS Comparison
NXT vs KRYS Comparison
Compare NXT & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXT
- KRYS
- Stock Information
- Founded
- NXT 2013
- KRYS 2015
- Country
- NXT United States
- KRYS United States
- Employees
- NXT N/A
- KRYS N/A
- Industry
- NXT Semiconductors
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NXT Technology
- KRYS Health Care
- Exchange
- NXT Nasdaq
- KRYS Nasdaq
- Market Cap
- NXT 8.8B
- KRYS 3.8B
- IPO Year
- NXT 2023
- KRYS 2017
- Fundamental
- Price
- NXT $54.34
- KRYS $137.67
- Analyst Decision
- NXT Buy
- KRYS Strong Buy
- Analyst Count
- NXT 20
- KRYS 8
- Target Price
- NXT $59.45
- KRYS $211.13
- AVG Volume (30 Days)
- NXT 2.1M
- KRYS 375.6K
- Earning Date
- NXT 07-31-2025
- KRYS 08-04-2025
- Dividend Yield
- NXT N/A
- KRYS N/A
- EPS Growth
- NXT 2.85
- KRYS 109.01
- EPS
- NXT 3.47
- KRYS 4.16
- Revenue
- NXT $2,959,197,000.00
- KRYS $333,448,000.00
- Revenue This Year
- NXT $13.48
- KRYS $44.05
- Revenue Next Year
- NXT $10.33
- KRYS $46.15
- P/E Ratio
- NXT $15.71
- KRYS $33.24
- Revenue Growth
- NXT 18.38
- KRYS 247.53
- 52 Week Low
- NXT $30.93
- KRYS $122.80
- 52 Week High
- NXT $63.19
- KRYS $219.34
- Technical
- Relative Strength Index (RSI)
- NXT 56.13
- KRYS 51.72
- Support Level
- NXT $54.00
- KRYS $127.99
- Resistance Level
- NXT $59.93
- KRYS $146.78
- Average True Range (ATR)
- NXT 2.31
- KRYS 5.32
- MACD
- NXT -0.58
- KRYS 1.54
- Stochastic Oscillator
- NXT 61.06
- KRYS 57.97
About NXT Nextracker Inc.
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.